Global Cord Blood (NYSE:CO) Now Covered by StockNews.com

Stock analysts at StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO) in a research report issued on Thursday. The brokerage set a “strong-buy” rating on the medical research company’s stock.

Global Cord Blood Price Performance

Global Cord Blood stock opened at $1.50 on Thursday. Global Cord Blood has a twelve month low of $2.03 and a twelve month high of $5.50. The company has a 50 day moving average of $1.47 and a 200-day moving average of $1.35. The stock has a market capitalization of $182.33 million, a PE ratio of 2.34 and a beta of 0.16.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.